CA2284795C - Novel pyrimidine derivatives and processes for the preparation thereof - Google Patents
Novel pyrimidine derivatives and processes for the preparation thereof Download PDFInfo
- Publication number
- CA2284795C CA2284795C CA002284795A CA2284795A CA2284795C CA 2284795 C CA2284795 C CA 2284795C CA 002284795 A CA002284795 A CA 002284795A CA 2284795 A CA2284795 A CA 2284795A CA 2284795 C CA2284795 C CA 2284795C
- Authority
- CA
- Canada
- Prior art keywords
- methyl
- pyrimidine
- fluorophenylamino
- dimethyl
- tetrahydroisoquinolin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000003230 pyrimidines Chemical class 0.000 title claims abstract description 20
- 238000000034 method Methods 0.000 title abstract description 93
- 238000002360 preparation method Methods 0.000 title abstract description 26
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 title abstract description 11
- -1 3-trifluoromethylphenylmethyl Chemical group 0.000 claims abstract description 68
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 46
- 239000001257 hydrogen Substances 0.000 claims abstract description 46
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 25
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 19
- 150000003839 salts Chemical class 0.000 claims abstract description 19
- 229910052736 halogen Chemical group 0.000 claims abstract description 12
- 150000002367 halogens Chemical group 0.000 claims abstract description 12
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 7
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 6
- 125000004849 alkoxymethyl group Chemical group 0.000 claims abstract description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 6
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims abstract description 6
- 125000004848 alkoxyethyl group Chemical group 0.000 claims abstract description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 5
- 150000002431 hydrogen Chemical group 0.000 claims abstract description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims abstract description 4
- 125000004372 methylthioethyl group Chemical group [H]C([H])([H])SC([H])([H])C([H])([H])* 0.000 claims abstract description 4
- 125000001064 morpholinomethyl group Chemical group [H]C([H])(*)N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H] 0.000 claims abstract description 4
- 125000001624 naphthyl group Chemical group 0.000 claims abstract description 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims description 202
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 59
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
- 229910052799 carbon Inorganic materials 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- HAASDWOKLDBJAK-UHFFFAOYSA-N [2-(4-fluoroanilino)-4-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-5-yl]methanol Chemical compound C1CC2=CC=CC=C2C(C)N1C(C(=C(C)N=1)CO)=NC=1NC1=CC=C(F)C=C1 HAASDWOKLDBJAK-UHFFFAOYSA-N 0.000 claims description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 5
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 2
- MELAICPHFIDWPI-LUTIACGYSA-N [2-(4-fluoroanilino)-5-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-4-yl]methyl (2s)-2-amino-3-methylbutanoate Chemical compound N=1C(N2C(C3=CC=CC=C3CC2)C)=C(C)C(COC(=O)[C@@H](N)C(C)C)=NC=1NC1=CC=C(F)C=C1 MELAICPHFIDWPI-LUTIACGYSA-N 0.000 claims description 2
- UTRGXAOOUSKFCH-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 2,3,4,5-tetrafluorobenzoate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)C1=CC(F)=C(F)C(F)=C1F UTRGXAOOUSKFCH-UHFFFAOYSA-N 0.000 claims description 2
- HLNJBKUNHKPSIF-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 2,3,4-trifluorobenzoate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)C1=CC=C(F)C(F)=C1F HLNJBKUNHKPSIF-UHFFFAOYSA-N 0.000 claims description 2
- QQWIJYAHRQQLHU-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 2,3,6-trifluorobenzoate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)C1=C(F)C=CC(F)=C1F QQWIJYAHRQQLHU-UHFFFAOYSA-N 0.000 claims description 2
- NABQSPFBADDJQP-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 2,4,5-trifluorobenzoate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)C1=CC(F)=C(F)C=C1F NABQSPFBADDJQP-UHFFFAOYSA-N 0.000 claims description 2
- IEOHHYXMYBNALF-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 2,4,6-trichlorobenzoate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)C1=C(Cl)C=C(Cl)C=C1Cl IEOHHYXMYBNALF-UHFFFAOYSA-N 0.000 claims description 2
- QJEIIVUCEMBHTH-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 2-(3-methoxyphenyl)acetate Chemical compound COC1=CC=CC(CC(=O)OC=2C=C3CCN(C(C)C3=CC=2)C=2C(=C(C)N=C(NC=3C=CC(F)=CC=3)N=2)C)=C1 QJEIIVUCEMBHTH-UHFFFAOYSA-N 0.000 claims description 2
- PRMHQZZFAQHHOP-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 2-(4-methoxyphenyl)acetate Chemical compound C1=CC(OC)=CC=C1CC(=O)OC1=CC=C(C(C)N(CC2)C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)C2=C1 PRMHQZZFAQHHOP-UHFFFAOYSA-N 0.000 claims description 2
- RXVSMDZYRCAYMM-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 3-(trifluoromethyl)benzoate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)C1=CC=CC(C(F)(F)F)=C1 RXVSMDZYRCAYMM-UHFFFAOYSA-N 0.000 claims description 2
- XTGQLXDKMQDORS-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] 2,3-difluorobenzoate Chemical compound C1=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=C1OC(=O)C1=CC=CC(F)=C1F XTGQLXDKMQDORS-UHFFFAOYSA-N 0.000 claims description 2
- PCNQAMUFPURFQL-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] 2-(3-methoxyphenyl)acetate Chemical compound COC1=CC=CC(CC(=O)OC=2C=C3C(C)N(CCC3=CC=2)C=2C(=C(C)N=C(NC=3C=CC(F)=CC=3)N=2)C)=C1 PCNQAMUFPURFQL-UHFFFAOYSA-N 0.000 claims description 2
- SKLJBQAVAONXEO-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] 2-(4-methoxyphenyl)acetate Chemical compound C1=CC(OC)=CC=C1CC(=O)OC1=CC=C(CCN(C2C)C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)C2=C1 SKLJBQAVAONXEO-UHFFFAOYSA-N 0.000 claims description 2
- BGBCLJIKHCPCGO-UHFFFAOYSA-N [[2-(4-fluoroanilino)-5-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-4-yl]-thiophen-2-ylmethyl] acetate Chemical compound C1CC2=CC=CC=C2C(C)N1C(C(=C(C(OC(C)=O)C=1SC=CC=1)N=1)C)=NC=1NC1=CC=C(F)C=C1 BGBCLJIKHCPCGO-UHFFFAOYSA-N 0.000 claims description 2
- XOFRRCLMKZCDIZ-YQAGWJQESA-N [2-(4-fluoroanilino)-5-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-4-yl]methyl (2s)-2-amino-3-phenylpropanoate Chemical compound C1CC2=CC=CC=C2C(C)N1C(C(=C(COC(=O)[C@@H](N)CC=1C=CC=CC=1)N=1)C)=NC=1NC1=CC=C(F)C=C1 XOFRRCLMKZCDIZ-YQAGWJQESA-N 0.000 claims 1
- NZVQGOFXUNABDV-UHFFFAOYSA-N [2-(4-fluoroanilino)-5-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-4-yl]methyl 4-propylbenzoate Chemical compound C1=CC(CCC)=CC=C1C(=O)OCC1=NC(NC=2C=CC(F)=CC=2)=NC(N2C(C3=CC=CC=C3CC2)C)=C1C NZVQGOFXUNABDV-UHFFFAOYSA-N 0.000 claims 1
- ZVOANXVHMLFIDF-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 2-chlorobenzoate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)C1=CC=CC=C1Cl ZVOANXVHMLFIDF-UHFFFAOYSA-N 0.000 claims 1
- DQWINXRKSPEREL-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 2-phenylmethoxyacetate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)COCC1=CC=CC=C1 DQWINXRKSPEREL-UHFFFAOYSA-N 0.000 claims 1
- GIJCCRIGUVYBSN-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 3-cyanobenzoate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)C1=CC=CC(C#N)=C1 GIJCCRIGUVYBSN-UHFFFAOYSA-N 0.000 claims 1
- KSGDVBXJPNXIKX-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 3-phenylprop-2-enoate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)C=CC1=CC=CC=C1 KSGDVBXJPNXIKX-UHFFFAOYSA-N 0.000 claims 1
- RIKPEGNSHSCKKI-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 4-(trifluoromethyl)benzoate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)C1=CC=C(C(F)(F)F)C=C1 RIKPEGNSHSCKKI-UHFFFAOYSA-N 0.000 claims 1
- AIKIFAMWBPZEDX-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 4-butoxybenzoate Chemical compound C1=CC(OCCCC)=CC=C1C(=O)OC1=CC=C(C(C)N(CC2)C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)C2=C1 AIKIFAMWBPZEDX-UHFFFAOYSA-N 0.000 claims 1
- KLBZEZIEIVPJGX-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 4-chlorobenzoate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)C1=CC=C(Cl)C=C1 KLBZEZIEIVPJGX-UHFFFAOYSA-N 0.000 claims 1
- MWCOKDSJYBTTDD-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 4-ethylbenzoate Chemical compound C1=CC(CC)=CC=C1C(=O)OC1=CC=C(C(C)N(CC2)C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)C2=C1 MWCOKDSJYBTTDD-UHFFFAOYSA-N 0.000 claims 1
- PWWLUWYTNHXCDJ-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 4-methylbenzoate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)C1=CC=C(C)C=C1 PWWLUWYTNHXCDJ-UHFFFAOYSA-N 0.000 claims 1
- UFINUWFRDLBXEV-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 4-nitrobenzoate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)C1=CC=C([N+]([O-])=O)C=C1 UFINUWFRDLBXEV-UHFFFAOYSA-N 0.000 claims 1
- ROKRZOVDIJHWIB-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 4-propylbenzoate Chemical compound C1=CC(CCC)=CC=C1C(=O)OC1=CC=C(C(C)N(CC2)C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)C2=C1 ROKRZOVDIJHWIB-UHFFFAOYSA-N 0.000 claims 1
- WJQGMXFNVJFELI-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 4-tert-butylbenzoate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)C1=CC=C(C(C)(C)C)C=C1 WJQGMXFNVJFELI-UHFFFAOYSA-N 0.000 claims 1
- MIUZSFKJCQNNLJ-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] 2-chlorobenzoate Chemical compound C1=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=C1OC(=O)C1=CC=CC=C1Cl MIUZSFKJCQNNLJ-UHFFFAOYSA-N 0.000 claims 1
- JURVLKRHZDVLSE-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] 3-(trifluoromethyl)benzoate Chemical compound C1=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=C1OC(=O)C1=CC=CC(C(F)(F)F)=C1 JURVLKRHZDVLSE-UHFFFAOYSA-N 0.000 claims 1
- AEKZJUBETLRWAH-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] 3-cyanobenzoate Chemical compound C1=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=C1OC(=O)C1=CC=CC(C#N)=C1 AEKZJUBETLRWAH-UHFFFAOYSA-N 0.000 claims 1
- IGHOKMXMBOWXHL-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] 3-fluorobenzoate Chemical compound C1=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=C1OC(=O)C1=CC=CC(F)=C1 IGHOKMXMBOWXHL-UHFFFAOYSA-N 0.000 claims 1
- ILIPORGEJNIDGJ-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] 4-methylbenzoate Chemical compound C1=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=C1OC(=O)C1=CC=C(C)C=C1 ILIPORGEJNIDGJ-UHFFFAOYSA-N 0.000 claims 1
- RSBGNYFOPWXZBK-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] 4-nitrobenzoate Chemical compound C1=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=C1OC(=O)C1=CC=C([N+]([O-])=O)C=C1 RSBGNYFOPWXZBK-UHFFFAOYSA-N 0.000 claims 1
- SMJQMCAVHIEZKG-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] 4-pentylbenzoate Chemical compound C1=CC(CCCCC)=CC=C1C(=O)OC1=CC=C(CCN(C2C)C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)C2=C1 SMJQMCAVHIEZKG-UHFFFAOYSA-N 0.000 claims 1
- IWSDEZHPXNCUHQ-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] 4-propylbenzoate Chemical compound C1=CC(CCC)=CC=C1C(=O)OC1=CC=C(CCN(C2C)C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)C2=C1 IWSDEZHPXNCUHQ-UHFFFAOYSA-N 0.000 claims 1
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 abstract description 5
- 239000004480 active ingredient Substances 0.000 abstract description 4
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 4
- 230000001262 anti-secretory effect Effects 0.000 abstract description 3
- 239000000543 intermediate Substances 0.000 abstract description 3
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 abstract description 3
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract description 3
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 abstract description 2
- 125000006515 benzyloxy alkyl group Chemical group 0.000 abstract description 2
- 125000004399 C1-C4 alkenyl group Chemical group 0.000 abstract 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 229
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 192
- 238000005481 NMR spectroscopy Methods 0.000 description 152
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 147
- 101150041968 CDC13 gene Proteins 0.000 description 114
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 108
- 229940086542 triethylamine Drugs 0.000 description 76
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 68
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 51
- 238000005160 1H NMR spectroscopy Methods 0.000 description 45
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 44
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 39
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 35
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 33
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 32
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- 229940035423 ethyl ether Drugs 0.000 description 27
- 239000011541 reaction mixture Substances 0.000 description 25
- 230000002829 reductive effect Effects 0.000 description 25
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 239000012044 organic layer Substances 0.000 description 22
- 239000007787 solid Substances 0.000 description 22
- 239000000203 mixture Substances 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 19
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 19
- 235000019439 ethyl acetate Nutrition 0.000 description 17
- 229940093499 ethyl acetate Drugs 0.000 description 17
- IDXKTTNFXPPXJY-UHFFFAOYSA-N pyrimidin-1-ium;chloride Chemical compound Cl.C1=CN=CN=C1 IDXKTTNFXPPXJY-UHFFFAOYSA-N 0.000 description 17
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- 239000002253 acid Substances 0.000 description 14
- 238000010898 silica gel chromatography Methods 0.000 description 14
- 239000002904 solvent Substances 0.000 description 13
- 239000000725 suspension Substances 0.000 description 13
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 235000019441 ethanol Nutrition 0.000 description 12
- SCFDZWASOUFVBE-UHFFFAOYSA-N 2-(2-chloro-5,6-dimethylpyrimidin-4-yl)-1-methyl-3,4-dihydro-1h-isoquinoline Chemical compound C1CC2=CC=CC=C2C(C)N1C1=NC(Cl)=NC(C)=C1C SCFDZWASOUFVBE-UHFFFAOYSA-N 0.000 description 11
- 102100021904 Potassium-transporting ATPase alpha chain 1 Human genes 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- BORJVRHSXJQZQT-UHFFFAOYSA-N 2-(2-chloro-5,6-dimethylpyrimidin-4-yl)-3,4-dihydro-1h-isoquinoline Chemical compound CC1=NC(Cl)=NC(N2CC3=CC=CC=C3CC2)=C1C BORJVRHSXJQZQT-UHFFFAOYSA-N 0.000 description 10
- 108010083204 Proton Pumps Proteins 0.000 description 10
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 10
- DRGCXLJWMQGVJA-UHFFFAOYSA-N pyrimidine;dihydrochloride Chemical compound Cl.Cl.C1=CN=CN=C1 DRGCXLJWMQGVJA-UHFFFAOYSA-N 0.000 description 10
- KRZCOLNOCZKSDF-UHFFFAOYSA-N 4-fluoroaniline Chemical compound NC1=CC=C(F)C=C1 KRZCOLNOCZKSDF-UHFFFAOYSA-N 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 9
- 229920006395 saturated elastomer Polymers 0.000 description 9
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical class C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 8
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 8
- MXMLBPWGHPXZRW-UHFFFAOYSA-N [2-(4-fluoroanilino)-5-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-4-yl]methanol Chemical compound C1CC2=CC=CC=C2C(C)N1C(C(=C(CO)N=1)C)=NC=1NC1=CC=C(F)C=C1 MXMLBPWGHPXZRW-UHFFFAOYSA-N 0.000 description 8
- 239000002585 base Substances 0.000 description 8
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Substances O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 8
- 239000010410 layer Substances 0.000 description 8
- 229960000381 omeprazole Drugs 0.000 description 8
- DYXPYDSFGXASRO-UHFFFAOYSA-N 2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-ol Chemical compound C1CC2=CC=C(O)C=C2C(C)N1C(C(=C(C)N=1)C)=NC=1NC1=CC=C(F)C=C1 DYXPYDSFGXASRO-UHFFFAOYSA-N 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 210000004051 gastric juice Anatomy 0.000 description 7
- BFXIDUSEHNCLTP-UHFFFAOYSA-N 2,4-dichloro-5,6-dimethylpyrimidine Chemical compound CC1=NC(Cl)=NC(Cl)=C1C BFXIDUSEHNCLTP-UHFFFAOYSA-N 0.000 description 6
- FEOTVFZHCHZXJX-UHFFFAOYSA-N 2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-ol Chemical compound C1CC2=CC(O)=CC=C2C(C)N1C(C(=C(C)N=1)C)=NC=1NC1=CC=C(F)C=C1 FEOTVFZHCHZXJX-UHFFFAOYSA-N 0.000 description 6
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- GPWHDDKQSYOYBF-UHFFFAOYSA-N ac1l2u0q Chemical compound Br[Br-]Br GPWHDDKQSYOYBF-UHFFFAOYSA-N 0.000 description 6
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 6
- SZXBQTSZISFIAO-ZETCQYMHSA-N (2s)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)OC(C)(C)C SZXBQTSZISFIAO-ZETCQYMHSA-N 0.000 description 5
- SCPUERXVEBRZMV-UHFFFAOYSA-N 2,4-dichloro-6-(methoxymethyl)-5-methylpyrimidine Chemical compound COCC1=NC(Cl)=NC(Cl)=C1C SCPUERXVEBRZMV-UHFFFAOYSA-N 0.000 description 5
- ICGYBJNONRDZOP-UHFFFAOYSA-N 2-morpholin-4-ium-4-ylacetic acid;chloride Chemical compound Cl.OC(=O)CN1CCOCC1 ICGYBJNONRDZOP-UHFFFAOYSA-N 0.000 description 5
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 5
- 238000004440 column chromatography Methods 0.000 description 5
- 239000005457 ice water Substances 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 229940126409 proton pump inhibitor Drugs 0.000 description 5
- 239000000612 proton pump inhibitor Substances 0.000 description 5
- ZYJPUMXJBDHSIF-NSHDSACASA-N (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ZYJPUMXJBDHSIF-NSHDSACASA-N 0.000 description 4
- PGASJMSZUPLNTH-UHFFFAOYSA-N 2-(4-benzylpiperazin-1-yl)acetic acid;dihydrochloride Chemical compound Cl.Cl.C1CN(CC(=O)O)CCN1CC1=CC=CC=C1 PGASJMSZUPLNTH-UHFFFAOYSA-N 0.000 description 4
- KDSNLYIMUZNERS-UHFFFAOYSA-N 2-methylpropanamine Chemical compound CC(C)CN KDSNLYIMUZNERS-UHFFFAOYSA-N 0.000 description 4
- WKVJGLBBPPFCGD-UHFFFAOYSA-N 2-piperidin-1-ium-1-ylacetic acid;chloride Chemical compound Cl.OC(=O)CN1CCCCC1 WKVJGLBBPPFCGD-UHFFFAOYSA-N 0.000 description 4
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000012346 acetyl chloride Substances 0.000 description 4
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 4
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical compound CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 description 4
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 4
- 235000013772 propylene glycol Nutrition 0.000 description 4
- 229960004063 propylene glycol Drugs 0.000 description 4
- 125000000714 pyrimidinyl group Chemical group 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- DQXIHLOJSHOJMV-UHFFFAOYSA-N 2-[2-chloro-6-(methoxymethyl)-5-methylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinoline Chemical compound COCC1=NC(Cl)=NC(N2C(C3=CC=CC=C3CC2)C)=C1C DQXIHLOJSHOJMV-UHFFFAOYSA-N 0.000 description 3
- QLJDWNGVIXFBPK-UHFFFAOYSA-N 2-[[4,5-dimethyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-2-yl]amino]-5-fluorophenol Chemical compound C1CC2=CC=CC=C2C(C)N1C(C(=C(C)N=1)C)=NC=1NC1=CC=C(F)C=C1O QLJDWNGVIXFBPK-UHFFFAOYSA-N 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- KIIKGHGBAFSTOE-UHFFFAOYSA-N 4-(5,8-dimethoxy-1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-(4-fluorophenyl)-5,6-dimethylpyrimidin-2-amine;hydrochloride Chemical compound Cl.C1CC=2C(OC)=CC=C(OC)C=2C(C)N1C(C(=C(C)N=1)C)=NC=1NC1=CC=C(F)C=C1 KIIKGHGBAFSTOE-UHFFFAOYSA-N 0.000 description 3
- FSCCJTKQQGRDAT-UHFFFAOYSA-N 6-methoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline Chemical compound CC1NCCC2=CC(OC)=CC=C21 FSCCJTKQQGRDAT-UHFFFAOYSA-N 0.000 description 3
- VMIDQQQAEQXCDJ-UHFFFAOYSA-N 7-methoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline Chemical compound C1CNC(C)C2=CC(OC)=CC=C21 VMIDQQQAEQXCDJ-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 3
- 150000001263 acyl chlorides Chemical class 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- PZTJJIUPKAYECR-UHFFFAOYSA-N n-(4-chloro-5,6-dimethylpyrimidin-2-yl)-4-methyl-1,3-thiazol-2-amine Chemical compound CC1=CSC(NC=2N=C(Cl)C(C)=C(C)N=2)=N1 PZTJJIUPKAYECR-UHFFFAOYSA-N 0.000 description 3
- QLPNGAQXBGGYRX-UHFFFAOYSA-N n-(4-fluorophenyl)-4-(6-methoxy-1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)-5,6-dimethylpyrimidin-2-amine;hydrochloride Chemical compound Cl.C1CC2=CC(OC)=CC=C2C(C)N1C(C(=C(C)N=1)C)=NC=1NC1=CC=C(F)C=C1 QLPNGAQXBGGYRX-UHFFFAOYSA-N 0.000 description 3
- UYXOVNNIRHAKPN-UHFFFAOYSA-N n-(4-fluorophenyl)-4-(7-methoxy-1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)-5,6-dimethylpyrimidin-2-amine;hydrochloride Chemical compound Cl.CC1C2=CC(OC)=CC=C2CCN1C(C(=C(C)N=1)C)=NC=1NC1=CC=C(F)C=C1 UYXOVNNIRHAKPN-UHFFFAOYSA-N 0.000 description 3
- AXIVWCJVHLOIHJ-UHFFFAOYSA-N n-(4-fluorophenyl)-4-(methoxymethyl)-6-(6-methoxy-1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)-5-methylpyrimidin-2-amine;hydrochloride Chemical compound Cl.N=1C(N2C(C3=CC=C(OC)C=C3CC2)C)=C(C)C(COC)=NC=1NC1=CC=C(F)C=C1 AXIVWCJVHLOIHJ-UHFFFAOYSA-N 0.000 description 3
- VTSRQYDCXGTZMF-UHFFFAOYSA-N n-(4-fluorophenyl)-4-[1-(methoxymethyl)-3,4-dihydro-1h-isoquinolin-2-yl]-5,6-dimethylpyrimidin-2-amine Chemical compound C1CC2=CC=CC=C2C(COC)N1C(C(=C(C)N=1)C)=NC=1NC1=CC=C(F)C=C1 VTSRQYDCXGTZMF-UHFFFAOYSA-N 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- CVQNVDFNUAHUOO-UHFFFAOYSA-N 1-(methoxymethyl)-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2C(COC)NCCC2=C1 CVQNVDFNUAHUOO-UHFFFAOYSA-N 0.000 description 2
- IQXXEPZFOOTTBA-UHFFFAOYSA-N 1-benzylpiperazine Chemical compound C=1C=CC=CC=1CN1CCNCC1 IQXXEPZFOOTTBA-UHFFFAOYSA-N 0.000 description 2
- QPILYVQSKNWRDD-UHFFFAOYSA-N 1-methyl-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2C(C)NCCC2=C1 QPILYVQSKNWRDD-UHFFFAOYSA-N 0.000 description 2
- IBRKLUSXDYATLG-UHFFFAOYSA-N 1-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol Chemical compound OC1=C(O)C=C2C(C)NCCC2=C1 IBRKLUSXDYATLG-UHFFFAOYSA-N 0.000 description 2
- QWGVLHXDJGMVBT-UHFFFAOYSA-N 2-(2-chloro-5,6-dimethylpyrimidin-4-yl)-5,8-dimethoxy-1-methyl-3,4-dihydro-1h-isoquinoline Chemical compound C1CC=2C(OC)=CC=C(OC)C=2C(C)N1C1=NC(Cl)=NC(C)=C1C QWGVLHXDJGMVBT-UHFFFAOYSA-N 0.000 description 2
- ODTDITRSNIQYMV-UHFFFAOYSA-N 2-(2-chloro-5,6-dimethylpyrimidin-4-yl)-6-methoxy-1-methyl-3,4-dihydro-1h-isoquinoline Chemical compound C1CC2=CC(OC)=CC=C2C(C)N1C1=NC(Cl)=NC(C)=C1C ODTDITRSNIQYMV-UHFFFAOYSA-N 0.000 description 2
- PYEGMPDTWADXSF-UHFFFAOYSA-N 2-(2-chloro-5,6-dimethylpyrimidin-4-yl)-7-methoxy-1-methyl-3,4-dihydro-1h-isoquinoline Chemical compound CC1C2=CC(OC)=CC=C2CCN1C1=NC(Cl)=NC(C)=C1C PYEGMPDTWADXSF-UHFFFAOYSA-N 0.000 description 2
- DOIJQFXXQBGGDO-UHFFFAOYSA-N 2-(4-fluoroanilino)-6-methyl-1h-pyrimidin-4-one Chemical compound N1C(C)=CC(=O)N=C1NC1=CC=C(F)C=C1 DOIJQFXXQBGGDO-UHFFFAOYSA-N 0.000 description 2
- PJHXVERCMAXEDT-UHFFFAOYSA-N 2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinoline-6,7-diol;hydrochloride Chemical compound Cl.C1CC2=CC(O)=C(O)C=C2C(C)N1C(C(=C(C)N=1)C)=NC=1NC1=CC=C(F)C=C1 PJHXVERCMAXEDT-UHFFFAOYSA-N 0.000 description 2
- NRHPBXWENYCPFC-UHFFFAOYSA-N 2-[2-chloro-6-(methoxymethyl)-5-methylpyrimidin-4-yl]-3,4-dihydro-1h-isoquinoline Chemical compound COCC1=NC(Cl)=NC(N2CC3=CC=CC=C3CC2)=C1C NRHPBXWENYCPFC-UHFFFAOYSA-N 0.000 description 2
- DBMYLQAWMBMWMG-UHFFFAOYSA-N 2-[2-chloro-6-(methoxymethyl)-5-methylpyrimidin-4-yl]-6-methoxy-1-methyl-3,4-dihydro-1h-isoquinoline Chemical compound COCC1=NC(Cl)=NC(N2C(C3=CC=C(OC)C=C3CC2)C)=C1C DBMYLQAWMBMWMG-UHFFFAOYSA-N 0.000 description 2
- GMCUTBZAYPXCOC-UHFFFAOYSA-N 2-methoxy-n-(2-phenylethyl)acetamide Chemical compound COCC(=O)NCCC1=CC=CC=C1 GMCUTBZAYPXCOC-UHFFFAOYSA-N 0.000 description 2
- QKPVEISEHYYHRH-UHFFFAOYSA-N 2-methoxyacetonitrile Chemical compound COCC#N QKPVEISEHYYHRH-UHFFFAOYSA-N 0.000 description 2
- ASUDFOJKTJLAIK-UHFFFAOYSA-N 2-methoxyethanamine Chemical compound COCCN ASUDFOJKTJLAIK-UHFFFAOYSA-N 0.000 description 2
- XBPOHKGSTPBJOS-UHFFFAOYSA-N 4-(3,4-dihydro-1h-isoquinolin-2-yl)-6-(methoxymethyl)-5-methyl-n-(2-methylphenyl)pyrimidin-2-amine;hydrochloride Chemical compound Cl.N=1C(N2CC3=CC=CC=C3CC2)=C(C)C(COC)=NC=1NC1=CC=CC=C1C XBPOHKGSTPBJOS-UHFFFAOYSA-N 0.000 description 2
- BNRRMRUVYDETQC-UHFFFAOYSA-N 4-fluoro-2-methoxyaniline Chemical compound COC1=CC(F)=CC=C1N BNRRMRUVYDETQC-UHFFFAOYSA-N 0.000 description 2
- KMHLGVTVACLEJE-UHFFFAOYSA-N 4-fluoro-2-methylaniline Chemical compound CC1=CC(F)=CC=C1N KMHLGVTVACLEJE-UHFFFAOYSA-N 0.000 description 2
- RPAIHIMDLRNHLQ-UHFFFAOYSA-N 5,6-dimethyl-2-[(4-methyl-1,3-thiazol-2-yl)amino]-1h-pyrimidin-4-one Chemical compound CC1=CSC(NC=2N=C(O)C(C)=C(C)N=2)=N1 RPAIHIMDLRNHLQ-UHFFFAOYSA-N 0.000 description 2
- JRTPSRIDBWIDOB-UHFFFAOYSA-N 5,6-dimethyl-2-[(4-phenyl-1,3-thiazol-2-yl)amino]-1h-pyrimidin-4-one Chemical compound OC1=C(C)C(C)=NC(NC=2SC=C(N=2)C=2C=CC=CC=2)=N1 JRTPSRIDBWIDOB-UHFFFAOYSA-N 0.000 description 2
- JVPBCCHBTQZAKW-UHFFFAOYSA-N 5,8-dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline Chemical compound CC1NCCC2=C1C(OC)=CC=C2OC JVPBCCHBTQZAKW-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical compound COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 2
- ATDWJOOPFDQZNK-UHFFFAOYSA-N N-acetyltyramine Chemical compound CC(=O)NCCC1=CC=C(O)C=C1 ATDWJOOPFDQZNK-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 208000008469 Peptic Ulcer Diseases 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 2
- RNDRBPVTMKQIBA-UHFFFAOYSA-N [4-(2-acetamidoethyl)phenyl] acetate Chemical compound CC(=O)NCCC1=CC=C(OC(C)=O)C=C1 RNDRBPVTMKQIBA-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000012320 chlorinating reagent Substances 0.000 description 2
- 229940061627 chloromethyl methyl ether Drugs 0.000 description 2
- 239000007822 coupling agent Substances 0.000 description 2
- NISGSNTVMOOSJQ-UHFFFAOYSA-N cyclopentanamine Chemical compound NC1CCCC1 NISGSNTVMOOSJQ-UHFFFAOYSA-N 0.000 description 2
- 230000017858 demethylation Effects 0.000 description 2
- 238000010520 demethylation reaction Methods 0.000 description 2
- FNENWZWNOPCZGK-UHFFFAOYSA-N ethyl 2-methyl-3-oxobutanoate Chemical compound CCOC(=O)C(C)C(C)=O FNENWZWNOPCZGK-UHFFFAOYSA-N 0.000 description 2
- ODDDUGHVGAOYKN-UHFFFAOYSA-N ethyl 4-methoxy-2-methyl-3-oxobutanoate Chemical compound CCOC(=O)C(C)C(=O)COC ODDDUGHVGAOYKN-UHFFFAOYSA-N 0.000 description 2
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- RMIODHQZRUFFFF-UHFFFAOYSA-N methoxyacetic acid Chemical compound COCC(O)=O RMIODHQZRUFFFF-UHFFFAOYSA-N 0.000 description 2
- DJXUZFZDNCZADC-UHFFFAOYSA-N n-(4-fluoro-2-methoxyphenyl)-4,5-dimethyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-2-amine Chemical compound COC1=CC(F)=CC=C1NC1=NC(C)=C(C)C(N2C(C3=CC=CC=C3CC2)C)=N1 DJXUZFZDNCZADC-UHFFFAOYSA-N 0.000 description 2
- RDQUNPMTLOWDGZ-UHFFFAOYSA-N n-(4-fluorophenyl)-4-(methoxymethyl)-5-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-2-amine;hydrochloride Chemical compound Cl.N=1C(N2C(C3=CC=CC=C3CC2)C)=C(C)C(COC)=NC=1NC1=CC=C(F)C=C1 RDQUNPMTLOWDGZ-UHFFFAOYSA-N 0.000 description 2
- FLOPYZXYIGHBJL-UHFFFAOYSA-N n-[2-(3-methoxyphenyl)ethyl]acetamide Chemical compound COC1=CC=CC(CCNC(C)=O)=C1 FLOPYZXYIGHBJL-UHFFFAOYSA-N 0.000 description 2
- NVSYANRBXPURRQ-UHFFFAOYSA-N naphthalen-1-ylmethanamine Chemical compound C1=CC=C2C(CN)=CC=CC2=C1 NVSYANRBXPURRQ-UHFFFAOYSA-N 0.000 description 2
- 208000011906 peptic ulcer disease Diseases 0.000 description 2
- 229940117803 phenethylamine Drugs 0.000 description 2
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 2
- 150000003246 quinazolines Chemical class 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 150000003526 tetrahydroisoquinolines Chemical group 0.000 description 2
- DZGWFCGJZKJUFP-UHFFFAOYSA-N tyramine Chemical compound NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- XINQFOMFQFGGCQ-UHFFFAOYSA-L (2-dodecoxy-2-oxoethyl)-[6-[(2-dodecoxy-2-oxoethyl)-dimethylazaniumyl]hexyl]-dimethylazanium;dichloride Chemical compound [Cl-].[Cl-].CCCCCCCCCCCCOC(=O)C[N+](C)(C)CCCCCC[N+](C)(C)CC(=O)OCCCCCCCCCCCC XINQFOMFQFGGCQ-UHFFFAOYSA-L 0.000 description 1
- KEEKMOIRJUWKNK-CABZTGNLSA-N (2S)-2-[[2-[(4R)-4-(difluoromethyl)-2-oxo-1,3-thiazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide Chemical compound FC([C@H]1N(C(SC1)=O)C=1N=C2N(CCOC3=C2C=CC(=C3)N[C@H](C(=O)N)C)C=1)F KEEKMOIRJUWKNK-CABZTGNLSA-N 0.000 description 1
- ABTKTFPXYSMVCT-WYYRYWFOSA-N (3S)-3-[benzyl-[(2-methylpropan-2-yl)oxycarbonyloxy]amino]-4-[[2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]-4-oxobutanoic acid Chemical compound CC=1C(=NC(=NC=1C)NC1=CC=C(C=C1)F)N1C(C2=CC(=CC=C2CC1)OC([C@@H](N(OC(=O)OC(C)(C)C)CC1=CC=CC=C1)CC(=O)O)=O)C ABTKTFPXYSMVCT-WYYRYWFOSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- NYNZQNWKBKUAII-KBXCAEBGSA-N (3s)-n-[5-[(2r)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide Chemical compound C1[C@@H](O)CCN1C(=O)NC1=C2N=C(N3[C@H](CCC3)C=3C(=CC=C(F)C=3)F)C=CN2N=C1 NYNZQNWKBKUAII-KBXCAEBGSA-N 0.000 description 1
- LCFFREMLXLZNHE-GBOLQPHISA-N (e)-2-[(3r)-3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile Chemical compound C12=C(N)N=CN=C2N([C@@H]2CCCN(C2)C(=O)C(/C#N)=C/C(C)(C)N2CCN(CC2)C2COC2)N=C1C(C(=C1)F)=CC=C1OC1=CC=CC=C1 LCFFREMLXLZNHE-GBOLQPHISA-N 0.000 description 1
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- OQSQWUHAKPOFAG-UHFFFAOYSA-N 1-o-ethyl 4-o-[[2-(4-fluoroanilino)-5-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-4-yl]methyl] butanedioate Chemical compound N=1C(N2C(C3=CC=CC=C3CC2)C)=C(C)C(COC(=O)CCC(=O)OCC)=NC=1NC1=CC=C(F)C=C1 OQSQWUHAKPOFAG-UHFFFAOYSA-N 0.000 description 1
- PCYKWRBZHPSIEO-YQAGWJQESA-N 1-o-tert-butyl 2-o-[2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] (2s)-pyrrolidine-1,2-dicarboxylate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)[C@@H]1CCCN1C(=O)OC(C)(C)C PCYKWRBZHPSIEO-YQAGWJQESA-N 0.000 description 1
- WLKMJXFOAKTUMW-YQAGWJQESA-N 1-o-tert-butyl 2-o-[2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] (2s)-pyrrolidine-1,2-dicarboxylate Chemical compound C1=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=C1OC(=O)[C@@H]1CCCN1C(=O)OC(C)(C)C WLKMJXFOAKTUMW-YQAGWJQESA-N 0.000 description 1
- KJUCPVIVNLPLEE-UHFFFAOYSA-N 2,6-difluoro-n-[2-fluoro-5-[5-[2-[(6-morpholin-4-ylpyridin-3-yl)amino]pyrimidin-4-yl]-2-propan-2-yl-1,3-thiazol-4-yl]phenyl]benzenesulfonamide Chemical compound S1C(C(C)C)=NC(C=2C=C(NS(=O)(=O)C=3C(=CC=CC=3F)F)C(F)=CC=2)=C1C(N=1)=CC=NC=1NC(C=N1)=CC=C1N1CCOCC1 KJUCPVIVNLPLEE-UHFFFAOYSA-N 0.000 description 1
- REIIYHICFMKMJN-UHFFFAOYSA-N 2-(2-chloro-5,6-dimethylpyrimidin-4-yl)-1-(methoxymethyl)-3,4-dihydro-1h-isoquinoline Chemical compound C1CC2=CC=CC=C2C(COC)N1C1=NC(Cl)=NC(C)=C1C REIIYHICFMKMJN-UHFFFAOYSA-N 0.000 description 1
- ZFPCFFMXYXBDEI-UHFFFAOYSA-N 2-(2-chloro-5,6-dimethylpyrimidin-4-yl)-1-methyl-3,4-dihydro-1h-isoquinoline-6,7-diol Chemical compound C1CC2=CC(O)=C(O)C=C2C(C)N1C1=NC(Cl)=NC(C)=C1C ZFPCFFMXYXBDEI-UHFFFAOYSA-N 0.000 description 1
- YACWHTXPHPKBLZ-UHFFFAOYSA-N 2-(2-chloro-5,6-dimethylpyrimidin-4-yl)-5-methoxy-1-methyl-3,4-dihydro-1h-isoquinoline Chemical compound C1CC=2C(OC)=CC=CC=2C(C)N1C1=NC(Cl)=NC(C)=C1C YACWHTXPHPKBLZ-UHFFFAOYSA-N 0.000 description 1
- WSWPCNMLEVZGSM-UHFFFAOYSA-N 2-(2-methoxyphenyl)ethanamine Chemical compound COC1=CC=CC=C1CCN WSWPCNMLEVZGSM-UHFFFAOYSA-N 0.000 description 1
- WJBMRZAHTUFBGE-UHFFFAOYSA-N 2-(3-methoxyphenyl)ethanamine Chemical compound COC1=CC=CC(CCN)=C1 WJBMRZAHTUFBGE-UHFFFAOYSA-N 0.000 description 1
- ATKMTPLTVGOTNA-UHFFFAOYSA-N 2-(4-benzylpiperazin-1-yl)acetic acid ethyl 2-(4-benzylpiperazin-1-yl)acetate dihydrochloride Chemical compound C(C1=CC=CC=C1)N1CCN(CC1)CC(=O)OCC.Cl.Cl.C(C1=CC=CC=C1)N1CCN(CC1)CC(=O)O ATKMTPLTVGOTNA-UHFFFAOYSA-N 0.000 description 1
- ALSZGSVMMWTAME-UHFFFAOYSA-N 2-(5,6-dimethyl-2-piperidin-1-ylpyrimidin-4-yl)-1-methyl-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2C(C)N1C(C(=C(C)N=1)C)=NC=1N1CCCCC1 ALSZGSVMMWTAME-UHFFFAOYSA-N 0.000 description 1
- BCSPNSLJLORXFK-UHFFFAOYSA-N 2-(5,6-dimethyl-2-piperidin-1-ylpyrimidin-4-yl)-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.N=1C(N2CC3=CC=CC=C3CC2)=C(C)C(C)=NC=1N1CCCCC1 BCSPNSLJLORXFK-UHFFFAOYSA-N 0.000 description 1
- VRPJIFMKZZEXLR-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid Chemical compound CC(C)(C)OC(=O)NCC(O)=O VRPJIFMKZZEXLR-UHFFFAOYSA-N 0.000 description 1
- KDDPNNXAZURUGP-UHFFFAOYSA-N 2-[2-(3,4-dichlorophenyl)-3-[2-(piperidin-3-ylamino)pyrimidin-4-yl]imidazol-4-yl]acetonitrile Chemical compound ClC=1C=C(C=CC=1Cl)C=1N(C(=CN=1)CC#N)C1=NC(=NC=C1)NC1CNCCC1 KDDPNNXAZURUGP-UHFFFAOYSA-N 0.000 description 1
- VXJIVGHBVZDQRF-UHFFFAOYSA-N 2-amino-4-(methoxymethyl)-5-methyl-1H-pyrimidin-6-one 6-(methoxymethyl)-5-methyl-1H-pyrimidine-2,4-dione Chemical compound NC1=NC(=C(C(=N1)O)C)COC.OC1=NC(=C(C(=N1)O)C)COC VXJIVGHBVZDQRF-UHFFFAOYSA-N 0.000 description 1
- LHASZEBEQGPCFM-CJFMBICVSA-N 2-amino-4-[(1r)-1-[[(6r)-6-[(5-chloro-2-methoxyphenyl)methyl]-7-oxo-3-(phenoxyamino)-5,6-dihydro-2h-1,4-diazepine-1-carbonyl]amino]propyl]benzoic acid Chemical compound C([C@@H]1CNC(CN(C1=O)C(=O)N[C@H](CC)C=1C=C(N)C(C(O)=O)=CC=1)=NOC=1C=CC=CC=1)C1=CC(Cl)=CC=C1OC LHASZEBEQGPCFM-CJFMBICVSA-N 0.000 description 1
- BZXNIJWQTYBJGO-UHFFFAOYSA-N 2-amino-6-(methoxymethyl)-5-methyl-1h-pyrimidin-4-one Chemical compound COCC1=NC(N)=NC(O)=C1C BZXNIJWQTYBJGO-UHFFFAOYSA-N 0.000 description 1
- UENGBOCGGKLVJJ-UHFFFAOYSA-N 2-chloro-1-(2,4-difluorophenyl)ethanone Chemical compound FC1=CC=C(C(=O)CCl)C(F)=C1 UENGBOCGGKLVJJ-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- BVGDAZBTIVRTGO-UONOGXRCSA-N 3-[(1r)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[4-methoxy-6-[(2s)-2-methylpiperazin-1-yl]pyridin-3-yl]pyridin-2-amine Chemical compound C1([C@@H](C)OC=2C(N)=NC=C(C=2)C2=CN=C(C=C2OC)N2[C@H](CNCC2)C)=C(Cl)C=CC(F)=C1Cl BVGDAZBTIVRTGO-UONOGXRCSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
- YKYYSYNAOLJPEX-UHFFFAOYSA-N 4,5-dimethyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-(2-phenylethyl)pyrimidin-2-amine;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2C(C)N1C(C(=C(C)N=1)C)=NC=1NCCC1=CC=CC=C1 YKYYSYNAOLJPEX-UHFFFAOYSA-N 0.000 description 1
- KNDMWCODJVITPD-UHFFFAOYSA-N 4,5-dimethyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-(naphthalen-1-ylmethyl)pyrimidin-2-amine;hydrochloride Chemical compound Cl.C1=CC=C2C(CNC=3N=C(C(=C(C)N=3)C)N3C(C4=CC=CC=C4CC3)C)=CC=CC2=C1 KNDMWCODJVITPD-UHFFFAOYSA-N 0.000 description 1
- IZLMEJVWIJVFLU-UHFFFAOYSA-N 4,5-dimethyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[[3-(trifluoromethyl)phenyl]methyl]pyrimidin-2-amine;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2C(C)N1C(C(=C(C)N=1)C)=NC=1NCC1=CC=CC(C(F)(F)F)=C1 IZLMEJVWIJVFLU-UHFFFAOYSA-N 0.000 description 1
- MXBJVFKSUUYHTD-UHFFFAOYSA-N 4,5-dimethyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-propylpyrimidin-2-amine;hydrochloride Chemical compound Cl.CCCNC1=NC(C)=C(C)C(N2C(C3=CC=CC=C3CC2)C)=N1 MXBJVFKSUUYHTD-UHFFFAOYSA-N 0.000 description 1
- GFQCRNXMHYSBCQ-UHFFFAOYSA-N 4-(3,4-dihydro-1h-isoquinolin-2-yl)-5,6-dimethyl-n-(2-methylpropyl)pyrimidin-2-amine;hydrochloride Chemical compound Cl.CC(C)CNC1=NC(C)=C(C)C(N2CC3=CC=CC=C3CC2)=N1 GFQCRNXMHYSBCQ-UHFFFAOYSA-N 0.000 description 1
- NXUPZKARUZTJCH-UHFFFAOYSA-N 4-(3,4-dihydro-1h-isoquinolin-2-yl)-5,6-dimethyl-n-(naphthalen-1-ylmethyl)pyrimidin-2-amine;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2CN1C1=C(C)C(C)=NC(NCC=2C3=CC=CC=C3C=CC=2)=N1 NXUPZKARUZTJCH-UHFFFAOYSA-N 0.000 description 1
- QPMFDSFYGZZZFZ-UHFFFAOYSA-N 4-(3,4-dihydro-1h-isoquinolin-2-yl)-5,6-dimethyl-n-propylpyrimidin-2-amine;hydrochloride Chemical compound Cl.CCCNC1=NC(C)=C(C)C(N2CC3=CC=CC=C3CC2)=N1 QPMFDSFYGZZZFZ-UHFFFAOYSA-N 0.000 description 1
- SRCHNVIRWKODBH-UHFFFAOYSA-N 4-(3,4-dihydro-1h-isoquinolin-2-yl)-n-(2-methoxyethyl)-5,6-dimethylpyrimidin-2-amine;hydrochloride Chemical compound Cl.COCCNC1=NC(C)=C(C)C(N2CC3=CC=CC=C3CC2)=N1 SRCHNVIRWKODBH-UHFFFAOYSA-N 0.000 description 1
- QDKRBQKYUIRUPV-UHFFFAOYSA-N 4-(3,4-dihydro-1h-isoquinolin-2-yl)-n-(4-fluoro-2-methylphenyl)-6-(methoxymethyl)-5-methylpyrimidin-2-amine;hydrochloride Chemical compound Cl.N=1C(N2CC3=CC=CC=C3CC2)=C(C)C(COC)=NC=1NC1=CC=C(F)C=C1C QDKRBQKYUIRUPV-UHFFFAOYSA-N 0.000 description 1
- BHVPHTSORHVUJR-UHFFFAOYSA-N 4-(3,4-dihydro-1h-isoquinolin-2-yl)-n-(4-fluorophenyl)-6-(methoxymethyl)-5-methylpyrimidin-2-amine;hydrochloride Chemical compound Cl.N=1C(N2CC3=CC=CC=C3CC2)=C(C)C(COC)=NC=1NC1=CC=C(F)C=C1 BHVPHTSORHVUJR-UHFFFAOYSA-N 0.000 description 1
- WTEARRHZCHSMTR-UHFFFAOYSA-N 4-(methoxymethyl)-5-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-(2-methylphenyl)pyrimidin-2-amine;hydrochloride Chemical compound Cl.N=1C(N2C(C3=CC=CC=C3CC2)C)=C(C)C(COC)=NC=1NC1=CC=CC=C1C WTEARRHZCHSMTR-UHFFFAOYSA-N 0.000 description 1
- DAERKFQKSUQXQL-UHFFFAOYSA-N 4-(methoxymethyl)-5-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-phenylpyrimidin-2-amine Chemical compound N=1C(N2C(C3=CC=CC=C3CC2)C)=C(C)C(COC)=NC=1NC1=CC=CC=C1 DAERKFQKSUQXQL-UHFFFAOYSA-N 0.000 description 1
- YFCIFWOJYYFDQP-PTWZRHHISA-N 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide Chemical compound CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1 YFCIFWOJYYFDQP-PTWZRHHISA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- JTSACJNLRWGUPN-UHFFFAOYSA-N 4-chloro-n-(4-fluorophenyl)-6-methylpyrimidin-2-amine Chemical compound CC1=CC(Cl)=NC(NC=2C=CC(F)=CC=2)=N1 JTSACJNLRWGUPN-UHFFFAOYSA-N 0.000 description 1
- WLKUSVNHZXUEFO-UHFFFAOYSA-N 4-fluoro-2-methoxy-1-nitrobenzene Chemical compound COC1=CC(F)=CC=C1[N+]([O-])=O WLKUSVNHZXUEFO-UHFFFAOYSA-N 0.000 description 1
- WIMSLPMGWNGYHX-UHFFFAOYSA-N 4-methyl-1,3-thiazole-2-carboximidamide;hydrochloride Chemical compound Cl.CC1=CSC(C(N)=N)=N1 WIMSLPMGWNGYHX-UHFFFAOYSA-N 0.000 description 1
- XJJWFMZGMOSXIL-UHFFFAOYSA-N 4-phenyl-1,3-thiazole-2-carboximidamide Chemical compound S1C(C(=N)N)=NC(C=2C=CC=CC=2)=C1 XJJWFMZGMOSXIL-UHFFFAOYSA-N 0.000 description 1
- JYWVXXASCLTVRN-UHFFFAOYSA-N 4-phenyl-1,3-thiazole-2-carboximidamide;hydrobromide Chemical compound Br.S1C(C(=N)N)=NC(C=2C=CC=CC=2)=C1 JYWVXXASCLTVRN-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- QQURWFRNETXFTN-UHFFFAOYSA-N 5-fluoro-2-nitrophenol Chemical compound OC1=CC(F)=CC=C1[N+]([O-])=O QQURWFRNETXFTN-UHFFFAOYSA-N 0.000 description 1
- XXJBJACMXXZTEM-UHFFFAOYSA-N 5-methoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline Chemical compound CC1NCCC2=C1C=CC=C2OC XXJBJACMXXZTEM-UHFFFAOYSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- MUFBHPRPPXNRKQ-UHFFFAOYSA-N 6-(methoxymethyl)-5-methyl-1h-pyrimidine-2,4-dione Chemical compound COCC1=NC(O)=NC(O)=C1C MUFBHPRPPXNRKQ-UHFFFAOYSA-N 0.000 description 1
- YRRBATAVUCSTRH-UHFFFAOYSA-N 6-methoxy-1-methyl-3,4-dihydroisoquinoline Chemical compound CC1=NCCC2=CC(OC)=CC=C21 YRRBATAVUCSTRH-UHFFFAOYSA-N 0.000 description 1
- WDYVUKGVKRZQNM-UHFFFAOYSA-N 6-phosphonohexylphosphonic acid Chemical compound OP(O)(=O)CCCCCCP(O)(O)=O WDYVUKGVKRZQNM-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- HBWFMVLNOKCVGK-WYYRYWFOSA-N CC=1C(=NC(=NC=1COC([C@@H](N(OC(=O)OC(C)(C)C)CC1=CC=CC=C1)CO)=O)NC1=CC=C(C=C1)F)N1C(C2=CC=CC=C2CC1)C Chemical compound CC=1C(=NC(=NC=1COC([C@@H](N(OC(=O)OC(C)(C)C)CC1=CC=CC=C1)CO)=O)NC1=CC=C(C=C1)F)N1C(C2=CC=CC=C2CC1)C HBWFMVLNOKCVGK-WYYRYWFOSA-N 0.000 description 1
- RNXTVCGTCBDFNC-UHFFFAOYSA-N COC=1C=C2CCN=C(C2=CC1)C.COC=1C=C2CCNC(C2=CC1)C Chemical compound COC=1C=C2CCN=C(C2=CC1)C.COC=1C=C2CCNC(C2=CC1)C RNXTVCGTCBDFNC-UHFFFAOYSA-N 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- LRULVYSBRWUVGR-FCHUYYIVSA-N GSK2879552 Chemical compound C1=CC(C(=O)O)=CC=C1CN1CCC(CN[C@H]2[C@@H](C2)C=2C=CC=CC=2)CC1 LRULVYSBRWUVGR-FCHUYYIVSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 101150086735 Lmo1 gene Proteins 0.000 description 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 description 1
- VIFWHZYHQSVJGD-UHFFFAOYSA-N N-[2-(4-methoxyphenyl)ethyl]acetamide Chemical compound COC1=CC=C(CCNC(C)=O)C=C1 VIFWHZYHQSVJGD-UHFFFAOYSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- QEXPWXSTGQYTDF-UHFFFAOYSA-N N1(CCCCC1)CC(=O)OCC.Cl.N1(CCCCC1)CC(=O)O Chemical compound N1(CCCCC1)CC(=O)OCC.Cl.N1(CCCCC1)CC(=O)O QEXPWXSTGQYTDF-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- UQONAEXHTGDOIH-AWEZNQCLSA-N O=C(N1CC[C@@H](C1)N1CCCC1=O)C1=CC2=C(NC3(CC3)CCO2)N=C1 Chemical compound O=C(N1CC[C@@H](C1)N1CCCC1=O)C1=CC2=C(NC3(CC3)CCO2)N=C1 UQONAEXHTGDOIH-AWEZNQCLSA-N 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 101100511353 Xenopus laevis lmo3 gene Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- JKFCCLGEGOJSOC-UHFFFAOYSA-N [2-(4-fluoroanilino)-4-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-5-yl]methyl acetate;dihydrochloride Chemical compound Cl.Cl.C1CC2=CC=CC=C2C(C)N1C(C(=C(C)N=1)COC(C)=O)=NC=1NC1=CC=C(F)C=C1 JKFCCLGEGOJSOC-UHFFFAOYSA-N 0.000 description 1
- AJOJUSZXEMIXAK-UQTORGHUSA-N [2-(4-fluoroanilino)-5-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-4-yl]methyl (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-methylsulfanylbutanoate Chemical compound N=1C(N2C(C3=CC=CC=C3CC2)C)=C(C)C(COC(=O)[C@@H](NC(=O)OC(C)(C)C)CCSC)=NC=1NC1=CC=C(F)C=C1 AJOJUSZXEMIXAK-UQTORGHUSA-N 0.000 description 1
- UVJXDSIMODYHLF-UHFFFAOYSA-N [2-(4-fluoroanilino)-5-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-4-yl]methyl 2-chlorobenzoate Chemical compound C1CC2=CC=CC=C2C(C)N1C(C(=C(COC(=O)C=1C(=CC=CC=1)Cl)N=1)C)=NC=1NC1=CC=C(F)C=C1 UVJXDSIMODYHLF-UHFFFAOYSA-N 0.000 description 1
- PMNDAGXDOPHTSH-UHFFFAOYSA-N [2-(4-fluoroanilino)-5-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-4-yl]methyl 2-methylpropanoate Chemical compound N=1C(N2C(C3=CC=CC=C3CC2)C)=C(C)C(COC(=O)C(C)C)=NC=1NC1=CC=C(F)C=C1 PMNDAGXDOPHTSH-UHFFFAOYSA-N 0.000 description 1
- JPUUBJKKZVZRGJ-UHFFFAOYSA-N [2-(4-fluoroanilino)-5-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-4-yl]methyl 3-cyanobenzoate Chemical compound C1CC2=CC=CC=C2C(C)N1C(C(=C(COC(=O)C=1C=C(C=CC=1)C#N)N=1)C)=NC=1NC1=CC=C(F)C=C1 JPUUBJKKZVZRGJ-UHFFFAOYSA-N 0.000 description 1
- LUWOVCPMNSFXCX-UHFFFAOYSA-N [2-(4-fluoroanilino)-5-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-4-yl]methyl 3-fluorobenzoate Chemical compound C1CC2=CC=CC=C2C(C)N1C(C(=C(COC(=O)C=1C=C(F)C=CC=1)N=1)C)=NC=1NC1=CC=C(F)C=C1 LUWOVCPMNSFXCX-UHFFFAOYSA-N 0.000 description 1
- ROJIPTRPEZBVEM-UHFFFAOYSA-N [2-(4-fluoroanilino)-5-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-4-yl]methyl 4-methylbenzoate Chemical compound C1CC2=CC=CC=C2C(C)N1C(C(=C(COC(=O)C=1C=CC(C)=CC=1)N=1)C)=NC=1NC1=CC=C(F)C=C1 ROJIPTRPEZBVEM-UHFFFAOYSA-N 0.000 description 1
- DULGCBBSWTWAKF-UHFFFAOYSA-N [2-(4-fluoroanilino)-5-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-4-yl]methyl 4-pentylbenzoate Chemical compound C1=CC(CCCCC)=CC=C1C(=O)OCC1=NC(NC=2C=CC(F)=CC=2)=NC(N2C(C3=CC=CC=C3CC2)C)=C1C DULGCBBSWTWAKF-UHFFFAOYSA-N 0.000 description 1
- ZJNAUEQEKMMMQZ-UHFFFAOYSA-N [2-(4-fluoroanilino)-5-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-4-yl]methyl acetate Chemical compound C1CC2=CC=CC=C2C(C)N1C(C(=C(COC(C)=O)N=1)C)=NC=1NC1=CC=C(F)C=C1 ZJNAUEQEKMMMQZ-UHFFFAOYSA-N 0.000 description 1
- ZATONFUGIMUNDW-UHFFFAOYSA-N [2-(4-fluoroanilino)-5-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-4-yl]methyl cyclopropanecarboxylate Chemical compound C1CC2=CC=CC=C2C(C)N1C(C(=C(COC(=O)C1CC1)N=1)C)=NC=1NC1=CC=C(F)C=C1 ZATONFUGIMUNDW-UHFFFAOYSA-N 0.000 description 1
- HLNUXWKOOCRATI-WYYRYWFOSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1H-isoquinolin-6-yl] (2S)-2-[benzyl-[(2-methylpropan-2-yl)oxycarbonyloxy]amino]-3-hydroxypropanoate Chemical compound CC=1C(=NC(=NC=1C)NC1=CC=C(C=C1)F)N1C(C2=CC=C(C=C2CC1)OC([C@@H](N(OC(=O)OC(C)(C)C)CC1=CC=CC=C1)CO)=O)C HLNUXWKOOCRATI-WYYRYWFOSA-N 0.000 description 1
- IQAIBGDMZLHQKG-WYYRYWFOSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1H-isoquinolin-7-yl] (2S)-2-[benzyl-[(2-methylpropan-2-yl)oxycarbonyloxy]amino]-3-hydroxypropanoate Chemical compound CC=1C(=NC(=NC=1C)NC1=CC=C(C=C1)F)N1C(C2=CC(=CC=C2CC1)OC([C@@H](N(OC(=O)OC(C)(C)C)CC1=CC=CC=C1)CO)=O)C IQAIBGDMZLHQKG-WYYRYWFOSA-N 0.000 description 1
- UVMSDDBACPNYDE-KEASEGHRSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoate Chemical compound C([C@@H](C(=O)OC=1C=C2CCN(C(C2=CC=1)C)C=1C(=C(C)N=C(NC=2C=CC(F)=CC=2)N=1)C)NC(=O)OC(C)(C)C)C1=CC=CC=C1 UVMSDDBACPNYDE-KEASEGHRSA-N 0.000 description 1
- PGLJVPSCVYGEGO-YQAGWJQESA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-methylsulfanylbutanoate Chemical compound C1CC2=CC(OC(=O)[C@@H](NC(=O)OC(C)(C)C)CCSC)=CC=C2C(C)N1C(C(=C(C)N=1)C)=NC=1NC1=CC=C(F)C=C1 PGLJVPSCVYGEGO-YQAGWJQESA-N 0.000 description 1
- HHPWBFIVJIKNFB-YQAGWJQESA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] (2s)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoate Chemical compound C1CC2=CC(OC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C)=CC=C2C(C)N1C(C(=C(C)N=1)C)=NC=1NC1=CC=C(F)C=C1 HHPWBFIVJIKNFB-YQAGWJQESA-N 0.000 description 1
- QNWAQZFZIDDTJD-BIAFCPFJSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] (2s)-4-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxobutanoate Chemical compound C1CC2=CC(OC(=O)[C@H](CC(N)=O)NC(=O)OC(C)(C)C)=CC=C2C(C)N1C(C(=C(C)N=1)C)=NC=1NC1=CC=C(F)C=C1 QNWAQZFZIDDTJD-BIAFCPFJSA-N 0.000 description 1
- YDPITNSZFFEHBF-GHZUAHJPSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] (2s)-5-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]-5-oxopentanoate Chemical compound C1CC2=CC(OC(=O)[C@H](CCC(N)=O)NC(=O)OC(C)(C)C)=CC=C2C(C)N1C(C(=C(C)N=1)C)=NC=1NC1=CC=C(F)C=C1 YDPITNSZFFEHBF-GHZUAHJPSA-N 0.000 description 1
- ZPFZAPAWVYPQQX-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 2,3-difluorobenzoate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)C1=CC=CC(F)=C1F ZPFZAPAWVYPQQX-UHFFFAOYSA-N 0.000 description 1
- LNNUPAGTHMEMDE-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 2,4-dichloro-5-fluorobenzoate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)C1=CC(F)=C(Cl)C=C1Cl LNNUPAGTHMEMDE-UHFFFAOYSA-N 0.000 description 1
- DJWVXDLCIYVNLH-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 2,4-difluorobenzoate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)C1=CC=C(F)C=C1F DJWVXDLCIYVNLH-UHFFFAOYSA-N 0.000 description 1
- ALCINUFSJKFMFY-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetate Chemical compound C1CC2=CC(OC(=O)CNC(=O)OC(C)(C)C)=CC=C2C(C)N1C(C(=C(C)N=1)C)=NC=1NC1=CC=C(F)C=C1 ALCINUFSJKFMFY-UHFFFAOYSA-N 0.000 description 1
- JCYCBQQUWMNQQI-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 2-morpholin-4-ylacetate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)CN1CCOCC1 JCYCBQQUWMNQQI-UHFFFAOYSA-N 0.000 description 1
- BVSULEFBTKJEKY-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] 2-thiophen-2-ylacetate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)CC1=CC=CS1 BVSULEFBTKJEKY-UHFFFAOYSA-N 0.000 description 1
- SBSHVCBGGJGHKB-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] cyclohexanecarboxylate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)C1CCCCC1 SBSHVCBGGJGHKB-UHFFFAOYSA-N 0.000 description 1
- VGRYGMABBBLWTJ-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-6-yl] cyclopropanecarboxylate Chemical compound C=1C=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=1OC(=O)C1CC1 VGRYGMABBBLWTJ-UHFFFAOYSA-N 0.000 description 1
- QCEZGQNHNOZBIN-KEASEGHRSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoate Chemical compound C([C@@H](C(=O)OC1=CC=C2CCN(C(C2=C1)C)C=1C(=C(C)N=C(NC=2C=CC(F)=CC=2)N=1)C)NC(=O)OC(C)(C)C)C1=CC=CC=C1 QCEZGQNHNOZBIN-KEASEGHRSA-N 0.000 description 1
- FEXYARDWZIOWAG-YQAGWJQESA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-methylsulfanylbutanoate Chemical compound CC1C2=CC(OC(=O)[C@@H](NC(=O)OC(C)(C)C)CCSC)=CC=C2CCN1C(C(=C(C)N=1)C)=NC=1NC1=CC=C(F)C=C1 FEXYARDWZIOWAG-YQAGWJQESA-N 0.000 description 1
- RYUOMCCNGFGNSZ-YQAGWJQESA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] (2s)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoate Chemical compound CC1C2=CC(OC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C)=CC=C2CCN1C(C(=C(C)N=1)C)=NC=1NC1=CC=C(F)C=C1 RYUOMCCNGFGNSZ-YQAGWJQESA-N 0.000 description 1
- NCTDLRAGHORHMC-BIAFCPFJSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] (2s)-4-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxobutanoate Chemical compound C1CC2=CC=C(OC(=O)[C@H](CC(N)=O)NC(=O)OC(C)(C)C)C=C2C(C)N1C(C(=C(C)N=1)C)=NC=1NC1=CC=C(F)C=C1 NCTDLRAGHORHMC-BIAFCPFJSA-N 0.000 description 1
- HXGGLOQWHMQFPU-GHZUAHJPSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] (2s)-5-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]-5-oxopentanoate Chemical compound C1CC2=CC=C(OC(=O)[C@H](CCC(N)=O)NC(=O)OC(C)(C)C)C=C2C(C)N1C(C(=C(C)N=1)C)=NC=1NC1=CC=C(F)C=C1 HXGGLOQWHMQFPU-GHZUAHJPSA-N 0.000 description 1
- RXTZJHRFTRTELV-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetate Chemical compound C1CC2=CC=C(OC(=O)CNC(=O)OC(C)(C)C)C=C2C(C)N1C(C(=C(C)N=1)C)=NC=1NC1=CC=C(F)C=C1 RXTZJHRFTRTELV-UHFFFAOYSA-N 0.000 description 1
- OFHRKYRYPQLXPV-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] 2-morpholin-4-ylacetate;dihydrochloride Chemical compound Cl.Cl.C1=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=C1OC(=O)CN1CCOCC1 OFHRKYRYPQLXPV-UHFFFAOYSA-N 0.000 description 1
- AFCZJUXSPKGQAK-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] 2-phenylmethoxyacetate Chemical compound C1=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=C1OC(=O)COCC1=CC=CC=C1 AFCZJUXSPKGQAK-UHFFFAOYSA-N 0.000 description 1
- PEKYRTKWJBIZIG-UHFFFAOYSA-N [2-[2-(4-fluoroanilino)-5,6-dimethylpyrimidin-4-yl]-1-methyl-3,4-dihydro-1h-isoquinolin-7-yl] 2-thiophen-2-ylacetate Chemical compound C1=C2C(C)N(C=3C(=C(C)N=C(NC=4C=CC(F)=CC=4)N=3)C)CCC2=CC=C1OC(=O)CC1=CC=CS1 PEKYRTKWJBIZIG-UHFFFAOYSA-N 0.000 description 1
- PJTBIKZSXHGTKZ-UHFFFAOYSA-N [2-anilino-5-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-4-yl]methanol;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2C(C)N1C(C(=C(CO)N=1)C)=NC=1NC1=CC=CC=C1 PJTBIKZSXHGTKZ-UHFFFAOYSA-N 0.000 description 1
- YKNZTUQUXUXTLE-UHFFFAOYSA-N [3-(trifluoromethyl)phenyl]methanamine Chemical compound NCC1=CC=CC(C(F)(F)F)=C1 YKNZTUQUXUXTLE-UHFFFAOYSA-N 0.000 description 1
- MPDUQYWJSYTCST-UHFFFAOYSA-N [K].FC1=CC(=C(C=C1)[N+](=O)[O-])OC Chemical compound [K].FC1=CC(=C(C=C1)[N+](=O)[O-])OC MPDUQYWJSYTCST-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- ZXPJBQLFCRVBDR-UHFFFAOYSA-N acetic acid;methanesulfonic acid Chemical compound CC(O)=O.CS(O)(=O)=O ZXPJBQLFCRVBDR-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- KDPAWGWELVVRCH-UHFFFAOYSA-M bromoacetate Chemical compound [O-]C(=O)CBr KDPAWGWELVVRCH-UHFFFAOYSA-M 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- LLADPGXAIXIKNJ-UHFFFAOYSA-N carbonic acid;2-(4-fluorophenyl)guanidine Chemical compound OC(O)=O.NC(N)=NC1=CC=C(F)C=C1 LLADPGXAIXIKNJ-UHFFFAOYSA-N 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 229940047583 cetamide Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- BULLHNJGPPOUOX-UHFFFAOYSA-N chloroacetone Chemical compound CC(=O)CCl BULLHNJGPPOUOX-UHFFFAOYSA-N 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- AKBSCGOUXFRZRP-UHFFFAOYSA-L dipotassium N-[2-(4-methoxyphenyl)ethyl]acetamide carbonate Chemical compound C([O-])([O-])=O.[K+].COC1=CC=C(C=C1)CCNC(C)=O.[K+] AKBSCGOUXFRZRP-UHFFFAOYSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- CGEGJBMEYWWPNX-UHFFFAOYSA-N ethyl 2-(4-benzylpiperazin-1-yl)acetate Chemical compound C1CN(CC(=O)OCC)CCN1CC1=CC=CC=C1 CGEGJBMEYWWPNX-UHFFFAOYSA-N 0.000 description 1
- ARFLASKVLJTEJD-UHFFFAOYSA-N ethyl 2-bromopropanoate Chemical compound CCOC(=O)C(C)Br ARFLASKVLJTEJD-UHFFFAOYSA-N 0.000 description 1
- SITMDWHJQROIPF-UHFFFAOYSA-N ethyl 2-morpholin-4-ylacetate Chemical compound CCOC(=O)CN1CCOCC1 SITMDWHJQROIPF-UHFFFAOYSA-N 0.000 description 1
- LXZHLNWWDDNIOJ-UHFFFAOYSA-N ethyl 2-piperidin-1-ylacetate Chemical compound CCOC(=O)CN1CCCCC1 LXZHLNWWDDNIOJ-UHFFFAOYSA-N 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical compound Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229960002523 mercuric chloride Drugs 0.000 description 1
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- JJUSTAVGGFEOJN-UHFFFAOYSA-N morpholin-4-yl acetate Chemical compound CC(=O)ON1CCOCC1 JJUSTAVGGFEOJN-UHFFFAOYSA-N 0.000 description 1
- MEJJSNJRZUBVCN-UHFFFAOYSA-N n-(4-chloro-5,6-dimethylpyrimidin-2-yl)-4-phenyl-1,3-thiazol-2-amine Chemical compound ClC1=C(C)C(C)=NC(NC=2SC=C(N=2)C=2C=CC=CC=2)=N1 MEJJSNJRZUBVCN-UHFFFAOYSA-N 0.000 description 1
- MDTAQVYGCCBSQV-UHFFFAOYSA-N n-(4-fluorophenyl)-4-(5-methoxy-1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)-5,6-dimethylpyrimidin-2-amine;hydrochloride Chemical compound Cl.C1CC=2C(OC)=CC=CC=2C(C)N1C(C(=C(C)N=1)C)=NC=1NC1=CC=C(F)C=C1 MDTAQVYGCCBSQV-UHFFFAOYSA-N 0.000 description 1
- ISUQYJHOJGBBGT-UHFFFAOYSA-N n-(4-fluorophenyl)-4-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-2-amine Chemical compound C1CC2=CC=CC=C2C(C)N1C(N=1)=CC(C)=NC=1NC1=CC=C(F)C=C1 ISUQYJHOJGBBGT-UHFFFAOYSA-N 0.000 description 1
- RFOBMWYZVKNDGE-UHFFFAOYSA-N n-(4-fluorophenyl)-5-(methoxymethyl)-4-methyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-2-amine;hydrochloride Chemical compound Cl.N1=C(N2C(C3=CC=CC=C3CC2)C)C(COC)=C(C)N=C1NC1=CC=C(F)C=C1 RFOBMWYZVKNDGE-UHFFFAOYSA-N 0.000 description 1
- BCXMZTBSKMPBRL-UHFFFAOYSA-N n-[4-(3,4-dihydro-1h-isoquinolin-2-yl)-5,6-dimethylpyrimidin-2-yl]-4-methyl-1,3-thiazol-2-amine;hydrochloride Chemical compound Cl.CC1=CSC(NC=2N=C(C(C)=C(C)N=2)N2CC3=CC=CC=C3CC2)=N1 BCXMZTBSKMPBRL-UHFFFAOYSA-N 0.000 description 1
- KWBOCIMQNXGNRM-UHFFFAOYSA-N n-butyl-4,5-dimethyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-2-amine;hydrochloride Chemical compound Cl.CCCCNC1=NC(C)=C(C)C(N2C(C3=CC=CC=C3CC2)C)=N1 KWBOCIMQNXGNRM-UHFFFAOYSA-N 0.000 description 1
- CYLFNDMUNBOSNU-UHFFFAOYSA-N n-butyl-4-(3,4-dihydro-1h-isoquinolin-2-yl)-5,6-dimethylpyrimidin-2-amine;hydrochloride Chemical compound Cl.CCCCNC1=NC(C)=C(C)C(N2CC3=CC=CC=C3CC2)=N1 CYLFNDMUNBOSNU-UHFFFAOYSA-N 0.000 description 1
- XVAPMDMOXIUMHE-UHFFFAOYSA-N n-cyclohexyl-4,5-dimethyl-6-(1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)pyrimidin-2-amine;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2C(C)N1C(C(=C(C)N=1)C)=NC=1NC1CCCCC1 XVAPMDMOXIUMHE-UHFFFAOYSA-N 0.000 description 1
- YXJWRKDDWQEOEL-UHFFFAOYSA-N n-cyclohexyl-4-(3,4-dihydro-1h-isoquinolin-2-yl)-5,6-dimethylpyrimidin-2-amine;hydrochloride Chemical compound Cl.N=1C(N2CC3=CC=CC=C3CC2)=C(C)C(C)=NC=1NC1CCCCC1 YXJWRKDDWQEOEL-UHFFFAOYSA-N 0.000 description 1
- CRRTZEDGZCXUFD-UHFFFAOYSA-N n-cyclopentyl-4-(3,4-dihydro-1h-isoquinolin-2-yl)-5,6-dimethylpyrimidin-2-amine;hydrochloride Chemical compound Cl.N=1C(N2CC3=CC=CC=C3CC2)=C(C)C(C)=NC=1NC1CCCC1 CRRTZEDGZCXUFD-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- XULSCZPZVQIMFM-IPZQJPLYSA-N odevixibat Chemical compound C12=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C=3C=CC(O)=CC=3)C=C2S(=O)(=O)NC(CCCC)(CCCC)CN1C1=CC=CC=C1 XULSCZPZVQIMFM-IPZQJPLYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- LIGACIXOYTUXAW-UHFFFAOYSA-N phenacyl bromide Chemical compound BrCC(=O)C1=CC=CC=C1 LIGACIXOYTUXAW-UHFFFAOYSA-N 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- OEBIHOVSAMBXIB-SJKOYZFVSA-N selitrectinib Chemical compound C[C@@H]1CCC2=NC=C(F)C=C2[C@H]2CCCN2C2=NC3=C(C=NN3C=C2)C(=O)N1 OEBIHOVSAMBXIB-SJKOYZFVSA-N 0.000 description 1
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1997/10863 | 1997-03-27 | ||
| KR19970010863 | 1997-03-27 | ||
| KR19970010862 | 1997-03-27 | ||
| KR1997/10862 | 1997-03-27 | ||
| PCT/KR1998/000058 WO1998043968A1 (en) | 1997-03-27 | 1998-03-24 | Novel pyrimidine derivatives and processes for the preparation thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2284795A1 CA2284795A1 (en) | 1998-10-08 |
| CA2284795C true CA2284795C (en) | 2004-01-20 |
Family
ID=26632616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002284795A Expired - Fee Related CA2284795C (en) | 1997-03-27 | 1998-03-24 | Novel pyrimidine derivatives and processes for the preparation thereof |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6352993B1 (enEXAMPLES) |
| EP (1) | EP1015444B1 (enEXAMPLES) |
| JP (1) | JP3176379B2 (enEXAMPLES) |
| KR (1) | KR100278857B1 (enEXAMPLES) |
| CN (1) | CN1118464C (enEXAMPLES) |
| AR (1) | AR012181A1 (enEXAMPLES) |
| AT (1) | ATE241613T1 (enEXAMPLES) |
| AU (1) | AU720385B2 (enEXAMPLES) |
| BR (1) | BR9808070A (enEXAMPLES) |
| CA (1) | CA2284795C (enEXAMPLES) |
| DE (1) | DE69815126T2 (enEXAMPLES) |
| DK (1) | DK1015444T3 (enEXAMPLES) |
| ES (1) | ES2200324T3 (enEXAMPLES) |
| HU (1) | HUP0000851A3 (enEXAMPLES) |
| IN (1) | IN188411B (enEXAMPLES) |
| PT (1) | PT1015444E (enEXAMPLES) |
| RU (1) | RU2203894C2 (enEXAMPLES) |
| TR (1) | TR199902383T2 (enEXAMPLES) |
| TW (1) | TW542831B (enEXAMPLES) |
| UY (1) | UY24938A1 (enEXAMPLES) |
| WO (1) | WO1998043968A1 (enEXAMPLES) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100272471B1 (ko) | 1998-11-17 | 2000-11-15 | 김선진 | 신규의 피리미딘 유도체 및 그의 제조방법 |
| US6852739B1 (en) | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
| TW200302728A (en) | 2002-02-01 | 2003-08-16 | Novartis Ag | Substituted amines as IgE inhibitors |
| EP1534278A4 (en) | 2002-08-01 | 2006-09-06 | Nitromed Inc | NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD |
| AU2004259346A1 (en) * | 2003-07-22 | 2005-02-03 | Neurogen Corporation | Substituted pyridin-2-ylamine analogues |
| CA2541989C (en) * | 2003-10-24 | 2013-10-01 | Exelixis, Inc. | P70s6 kinase modulators and method of use |
| WO2005041961A1 (en) | 2003-11-03 | 2005-05-12 | Astrazeneca Ab | Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux |
| KR101122376B1 (ko) * | 2005-03-09 | 2012-03-26 | 주식회사유한양행 | 신규의 5,6-다이메틸피리미딘 유도체 및 그의 제조방법 |
| US20090124645A1 (en) * | 2005-10-14 | 2009-05-14 | Neurosearch A/S | Novel Pyrimidine-2,4-Diamine Derivatives and their Use as Modulators of Small-Conductance Calcium-Activated Potassium Channels |
| JP4946482B2 (ja) | 2007-02-08 | 2012-06-06 | 船井電機株式会社 | 緩衝用梱包材及びｔｖ受像機の緩衝用梱包材 |
| US8367684B2 (en) * | 2007-06-13 | 2013-02-05 | Valeant Pharmaceuticals International | Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators |
| BRPI0917540A2 (pt) | 2008-08-05 | 2015-11-17 | Daiichi Sankyo Co Ltd | composto, sal farmacologicamente aceitavél, composição farmacêutica, e, uso de um composto ou sal farmacologicamente aceitável |
| GB0908394D0 (en) | 2009-05-15 | 2009-06-24 | Univ Leuven Kath | Novel viral replication inhibitors |
| GB0913636D0 (en) | 2009-08-05 | 2009-09-16 | Univ Leuven Kath | Novel viral replication inhibitors |
| CA2817165A1 (en) | 2010-11-15 | 2012-05-24 | Patrick Chaltin | Novel antiviral compounds |
| PL2678331T3 (pl) | 2011-02-25 | 2016-12-30 | Pochodne diaminopirymidyny i sposoby ich wytwarzania | |
| CN104203939B (zh) * | 2012-02-17 | 2017-06-06 | 艾伯维公司 | 用作人呼吸道合胞病毒（rsv）抑制剂的二氨基嘧啶 |
| US9309271B2 (en) | 2012-05-29 | 2016-04-12 | Momentive Performance Materials Gmbh | Preparation of isocyanato silanes |
| WO2014081906A2 (en) | 2012-11-21 | 2014-05-30 | Ptc Therapeutics, Inc. | Substituted reverse pyrimidine bmi-1 inhibitors |
| EP2970307B1 (en) | 2013-03-13 | 2020-03-11 | Genentech, Inc. | Pyrazolo compounds and uses thereof |
| EA034866B1 (ru) | 2013-08-30 | 2020-03-31 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Замещенные пиримидиновые ингибиторы bmi-1 |
| CN104903312B (zh) * | 2013-10-07 | 2019-01-29 | 卡德门企业有限公司 | Rho激酶抑制剂 |
| US10584115B2 (en) | 2013-11-21 | 2020-03-10 | Ptc Therapeutics, Inc. | Substituted pyridine and pyrazine BMI-1 inhibitors |
| US10370360B2 (en) | 2014-10-22 | 2019-08-06 | The Board Of Regents Of The University Of Texas System | Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof |
| CN105669642B (zh) * | 2014-11-19 | 2020-06-09 | 江苏天士力帝益药业有限公司 | 一种盐酸洛氟普啶的制备方法 |
| DK3400217T3 (da) * | 2016-01-04 | 2022-06-07 | Merck Serono Sa | L-valinat af hydroxypropylthiazolidincarboxamid-derivat, dets salt og krystalform deraf |
| WO2018184978A1 (de) * | 2017-04-05 | 2018-10-11 | Bayer Cropscience Aktiengesellschaft | 2-amino-5-oxyalkyl-pyrimidinderivate und deren verwendung zur bekämpfung unerwünschten pflanzenwachstums |
| US12023335B2 (en) | 2018-08-17 | 2024-07-02 | Ptc Therapeutics, Inc. | Method for treating pancreatic cancer |
| CN114685369B (zh) * | 2022-05-17 | 2024-02-02 | 河南省科学院高新技术研究中心 | 一种利用离子液体制备1-甲基-1,2,3,4-四氢异喹啉的方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1182584A (en) | 1966-03-31 | 1970-02-25 | Ici Ltd | Pyrimidine derivates and the use thereof as fungicides |
| US3980781A (en) | 1966-03-31 | 1976-09-14 | Imperial Chemical Industries Limited | Fungicidal composition and method containing 2-amino-pyrimidines |
| US4000138A (en) | 1966-03-31 | 1976-12-28 | Imperial Chemical Industries Limited | Organic compounds and compositions containing them |
| GB1383409A (en) | 1972-09-09 | 1974-02-12 | Pfizer Ltd | Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them |
| US4044136A (en) | 1972-09-09 | 1977-08-23 | Pfizer Inc. | Aminoquinazoline therapeutic agents |
| US3956495A (en) | 1973-10-30 | 1976-05-11 | Eli Lilly And Company | 2,4-Diaminoquinazolines as antithrombotic agents |
| US4755218A (en) | 1985-12-31 | 1988-07-05 | Monsanto Company | Haloacyl 1-substituted-1,2,3,4-tetrahydro-isoquinolines as herbicide antidotes |
| GB8621425D0 (en) * | 1986-09-05 | 1986-10-15 | Smith Kline French Lab | Compounds |
| IL88507A (en) * | 1987-12-03 | 1993-02-21 | Smithkline Beckman Intercredit | 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them |
| US4966622A (en) | 1988-04-12 | 1990-10-30 | Ciba-Geigy Corporation | N-phenyl-N-pyrimidin-2-ylureas |
| HU206337B (en) * | 1988-12-29 | 1992-10-28 | Mitsui Petrochemical Ind | Process for producing pyrimidine derivatives and pharmaceutical compositions |
| DE3901448A1 (de) | 1989-01-19 | 1990-07-26 | Basf Ag | Emulsionscopolymerisate |
| FI95376C (fi) | 1989-03-22 | 1996-01-25 | Ciba Geigy Ag | Mikrobisidiset 2-anilino-pyrimidiinijohdannaiset |
| CA2015981A1 (en) * | 1989-05-10 | 1990-11-10 | Thomas H. Brown | Compounds |
| GB8910722D0 (en) | 1989-05-10 | 1989-06-28 | Smithkline Beckman Intercredit | Compounds |
| GB9012592D0 (en) | 1990-06-06 | 1990-07-25 | Smithkline Beecham Intercredit | Compounds |
| US5444062A (en) | 1990-11-06 | 1995-08-22 | Pfizer Inc. | Quinazolines derivatives for enhancing antitumor activity |
| DE69201559T2 (de) | 1991-04-17 | 1995-07-13 | Pfizer | Pyrimidinderivate zur erhöhung der antitumoraktivität. |
| US5276186A (en) | 1992-03-11 | 1994-01-04 | Ciba-Geigy Corporation | Process for the production of guanidine derivatives |
| KR0144833B1 (ko) * | 1992-12-28 | 1998-07-15 | 김태훈 | 신규의 퀴나졸린 유도체 및 그의 제조방법 |
| HUT75876A (en) * | 1993-08-12 | 1997-05-28 | Astra Ab | Amidine derivatives with nitric oxide synthetase activities, pharmaceutical compositions containing them and process for their preparation |
| DK0640599T3 (da) | 1993-08-26 | 1998-09-28 | Ono Pharmaceutical Co | 4-Aminopyrimidin-derivater |
| RU2153494C2 (ru) | 1993-10-12 | 2000-07-27 | Дзе Дюпон Мерк Фармасьютикал Компани | 1-n-алкил-n-арилпиримидинамины, способ лечения заболеваний, фармацевтическая композиция |
| ES2201112T3 (es) | 1994-08-13 | 2004-03-16 | Yuhan Corporation | Nuevos derivados de pirimidina y procedimientos para su preparacion. |
| CA2358479C (en) * | 1996-05-04 | 2004-07-13 | Yuhan Corporation | 4-substituted-2-(4-fluorophenylamino)-5,6 dimethylpyrimidine |
-
1998
- 1998-03-23 IN IN724DE1998 patent/IN188411B/en unknown
- 1998-03-24 DK DK98911242T patent/DK1015444T3/da active
- 1998-03-24 JP JP54148798A patent/JP3176379B2/ja not_active Expired - Fee Related
- 1998-03-24 US US09/381,814 patent/US6352993B1/en not_active Expired - Fee Related
- 1998-03-24 TR TR1999/02383T patent/TR199902383T2/xx unknown
- 1998-03-24 ES ES98911242T patent/ES2200324T3/es not_active Expired - Lifetime
- 1998-03-24 HU HU0000851A patent/HUP0000851A3/hu unknown
- 1998-03-24 AT AT98911242T patent/ATE241613T1/de not_active IP Right Cessation
- 1998-03-24 CN CN98803765A patent/CN1118464C/zh not_active Expired - Fee Related
- 1998-03-24 EP EP98911242A patent/EP1015444B1/en not_active Expired - Lifetime
- 1998-03-24 DE DE69815126T patent/DE69815126T2/de not_active Expired - Fee Related
- 1998-03-24 PT PT98911242T patent/PT1015444E/pt unknown
- 1998-03-24 CA CA002284795A patent/CA2284795C/en not_active Expired - Fee Related
- 1998-03-24 RU RU99122603/04A patent/RU2203894C2/ru not_active IP Right Cessation
- 1998-03-24 BR BR9808070-9A patent/BR9808070A/pt not_active Application Discontinuation
- 1998-03-24 WO PCT/KR1998/000058 patent/WO1998043968A1/en active IP Right Grant
- 1998-03-24 AU AU65239/98A patent/AU720385B2/en not_active Ceased
- 1998-03-26 UY UY24938A patent/UY24938A1/es not_active IP Right Cessation
- 1998-03-26 AR ARP980101380A patent/AR012181A1/es unknown
- 1998-03-27 KR KR1019980010754A patent/KR100278857B1/ko not_active Expired - Fee Related
- 1998-03-27 TW TW087104605A patent/TW542831B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1118464C (zh) | 2003-08-20 |
| CA2284795A1 (en) | 1998-10-08 |
| JP2000513014A (ja) | 2000-10-03 |
| IN188411B (enEXAMPLES) | 2002-09-21 |
| AU6523998A (en) | 1998-10-22 |
| US6352993B1 (en) | 2002-03-05 |
| HK1026418A1 (en) | 2000-12-15 |
| EP1015444A1 (en) | 2000-07-05 |
| TR199902383T2 (xx) | 2000-06-21 |
| TW542831B (en) | 2003-07-21 |
| RU2203894C2 (ru) | 2003-05-10 |
| BR9808070A (pt) | 2000-03-08 |
| AU720385B2 (en) | 2000-06-01 |
| KR19980080789A (ko) | 1998-11-25 |
| WO1998043968A1 (en) | 1998-10-08 |
| DE69815126T2 (de) | 2004-04-08 |
| EP1015444B1 (en) | 2003-05-28 |
| JP3176379B2 (ja) | 2001-06-18 |
| HUP0000851A3 (en) | 2002-04-29 |
| HUP0000851A1 (hu) | 2001-04-28 |
| AR012181A1 (es) | 2000-09-27 |
| ATE241613T1 (de) | 2003-06-15 |
| CN1251586A (zh) | 2000-04-26 |
| PT1015444E (pt) | 2003-10-31 |
| UY24938A1 (es) | 2001-01-31 |
| KR100278857B1 (ko) | 2001-01-15 |
| ES2200324T3 (es) | 2004-03-01 |
| DE69815126D1 (de) | 2003-07-03 |
| DK1015444T3 (da) | 2003-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2284795C (en) | Novel pyrimidine derivatives and processes for the preparation thereof | |
| AU696390B2 (en) | Quinolones and their therapeutic use | |
| EP1979341B1 (en) | Trisubstituted amine compound | |
| CA2634676C (en) | Trisubstituted amine compounds as inhibitors of cholesteryl ester transfer protein cetp | |
| CA1279317C (en) | Piperidine derivative and pharmaceutical composition | |
| KR102098606B1 (ko) | 신규 아민 유도체 또는 그 염 | |
| DK2597955T3 (en) | QUINOLINE DERIVATIVES AND MILK INHIBITORS CONTAINING THESE | |
| AU2006330072B2 (en) | Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors | |
| IL105806A (en) | Aminoquinoline derivatives and pharmaceutical compositions containing the same | |
| WO2006073973A2 (en) | Novel benzylamine derivatives as cetp inhibitors | |
| CA2361402C (en) | Bis-sulfonamides | |
| EP2152672A1 (en) | Novel sulphoximine-substituted quinazoline and quinazoline derivatives as kinase inhibitors | |
| CA2241891A1 (en) | Quinolones and their therapeutic use | |
| AU2005300736B2 (en) | Anthranilamide pyridinureas as VEGF receptor kinase inhibitors | |
| AU2005228291A1 (en) | Tetrahydronaphthyridine derivatives and a process for preparing the same | |
| WO2004099187A1 (en) | N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof | |
| KR20240142481A (ko) | 엑토뉴클레오티드 피로포스파타제-포스포디에스테라제 1 (enpp1) 억제제 및 그의 용도 | |
| WO2007038387A2 (en) | Compounds and methods for the treatment of viruses and cancer | |
| US4824955A (en) | Selenium oxy chloride-pyridine or bipyridine complexes | |
| CA2351644A1 (en) | Pyrimidine derivatives and processes for the preparation thereof | |
| KR20220052333A (ko) | 근위축성 측색 경화증 및 관련 장애의 치료를 위한 tdp-43에 결합하는 분자 | |
| CZ12097A3 (en) | Trifluoromethylquinolinecarboxylic acid derivatives and pharmaceutical composition containing thereof | |
| TW202239409A (zh) | 化合物 | |
| KR20000017194A (ko) | 치환된 피리딘의 제조방법 | |
| WO2002083650A1 (en) | Novel sulfonylamino-pyrimidines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |